Trophos
Records under this name other than patents Trophos holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,320,745 | Use of cholest-4-en-3-one derivatives for obtaining a cytoprotective drug Lapsed on the fee record Ended Apr 26, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2024 | From the USPTO record |
| US 7,985,774 | Use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug Lapsed on the fee record Ended Jul 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 26, 2023 | From the USPTO record |
| US 9,045,393 | Derivatives of 3.5-seco-4-norcholestane and use thereof Lapsed on the fee record Ended Jun 2, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 2, 2023 | From the USPTO record |
| US 7,372,626 | Device for sequential observation of samples and methods using same Term ended Term ended Mar 21, 2023 · From the USPTO record | Term ended | Term ended Mar 21, 2023 | From the USPTO record |
| US 7,858,603 | Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof Lapsed on the fee record Ended Dec 28, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 28, 2022 | From the USPTO record |
| US 8,575,138 | Method for providing neuroprotection Lapsed on the fee record Ended Nov 5, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2021 | From the USPTO record |
| US 8,481,515 | Derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method Lapsed on the fee record Ended Jul 9, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 9, 2021 | From the USPTO record |
| US 8,354,395 | Method for providing neuroprotection from spinal muscular atrophy Lapsed on the fee record Ended Jan 15, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 15, 2021 | From the USPTO record |
| US 8,338,488 | Use of at least one oxime derivative of 3,5-seco-4-nor-cholestane as antioxidants Lapsed on the fee record Ended Dec 25, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 25, 2020 | From the USPTO record |
| US 8,283,341 | Use as medicaments of derivatives of cholest-4-en-3-one, pharmaceutical compositions containing them, novel derivatives and their preparation process Lapsed on the fee record Ended Oct 9, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 9, 2020 | From the USPTO record |